Bluebird Bio takes gene therapy into EMA's adaptive pathways pilot
This article was originally published in Scrip
Executive Summary
A total of 58 products have been submitted as potential candidates for the European Medicines Agency's adaptive pathways pilot, but the US company, bluebird bio, appears to be the first firm to have formally announced that it is taking this particular approach to approval.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.